title: Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.
abstract: Mammographic density (MD) adjusted for age and body mass index is one of the strongest known risk factors for breast cancer. Given the high attributable risk of MD for breast cancer, chemoprevention with a safe and available agent that reduces MD and breast cancer risk would be beneficial. Cox-2 has been implicated in MD-related breast cancer risk, and was increased in stromal cells in high MD tissues in one study. Our study assessed differential Cox-2 expression in epithelial and stromal cells in paired samples of high and low MD human breast tissue, and in a validated xenograft biochamber model of MD. We also examined the effects of endocrine treatment upon Cox-2 expression in high and low MD tissues in the MD xenograft model. Paired high and low MD human breast tissue samples were immunostained for Cox-2, then assessed for differential expression and staining intensity in epithelial and stromal cells. High and low MD human breast tissues were separately maintained in biochambers in mice treated with Tamoxifen, oestrogen or placebo implants, then assessed for percentage Cox-2 staining in epithelial and stromal cells. Percentage Cox-2 staining was greater for both epithelial (p = 0.01) and stromal cells (p < 0.0001) of high compared with low MD breast tissues. In high MD biochamber tissues, percentage Cox-2 staining was greater in stromal cells of oestrogen-treated versus placebo-treated tissues (p = 0.05).
authors.affiliation: University of Melbourne Department of Surgery, St Vincent's Hospital, Melbourne, VIC, Australia, gracelchew@gmail.com.
authors.forename: G L
authors.initials: GL
authors.lastname: Chew
authors.forename: C W
authors.initials: CW
authors.lastname: Huo
authors.forename: D
authors.initials: D
authors.lastname: Huang
authors.forename: P
authors.initials: P
authors.lastname: Hill
authors.forename: J
authors.initials: J
authors.lastname: Cawson
authors.forename: H
authors.initials: H
authors.lastname: Frazer
authors.forename: J L
authors.initials: JL
authors.lastname: Hopper
authors.forename: I
authors.initials: I
authors.lastname: Haviv
authors.forename: M A
authors.initials: MA
authors.lastname: Henderson
authors.forename: K
authors.initials: K
authors.lastname: Britt
authors.forename: E W
authors.initials: EW
authors.lastname: Thompson
mesh_terms: D000328:Adult; D000818:Animals; D001940:Breast / Q000378:metabolism / Q000473:pathology; D000071060:Breast Density; D001943:Breast Neoplasms / Q000378:metabolism* / Q000473:pathology*; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D004847:Epithelial Cells / Q000378:metabolism*; D005260:Female; D015870:Gene Expression; D064593:Heterografts; D006801:Humans; D007150:Immunohistochemistry; D042361:Mammary Glands, Human / Q000002:abnormalities; D051379:Mice; D008875:Middle Aged; D017154:Stromal Cells / Q000378:metabolism*
chemical_list: D051546:Cyclooxygenase 2